PHIN 214
Alternative Names: PHIN-214Latest Information Update: 21 Aug 2022
At a glance
- Originator PharmaIN
- Class Antidiuretics; Antihaemorrhagics; Antihypertensives; Vasoconstrictors; Vasopressins
- Mechanism of Action Vasopressin 1a receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Liver cirrhosis
Most Recent Events
- 03 Jan 2022 Phase-I clinical trials in Liver cirrhosis in USA (SC) (NCT05490888)